Trials / Sponsors / OcuTerra Therapeutics, Inc.
OcuTerra Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Nesvategrast (OTT166) in Diabetic Retinopathy (DR) Diabetic Retinopathy | Phase 2 | 2022-07-29 |
| Completed | Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degenerati Age-Related Macular Degeneration | Phase 1 / Phase 2 | 2016-10-05 |
| Completed | Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) Diabetic Macular Edema | Phase 1 / Phase 2 | 2016-08-24 |